ARTICLE | Company News
ViRexx Medical, National Research Council of Canada infectious news
June 4, 2007 7:00 AM UTC
The council will provide funding for its National Institute for Nanotechnology (NINT) to study the physical characteristics and immunological and nanoparticle-forming properties of VIR's Chimigen vacc...